Wegelius U - Search Results

1

The value of quantitative analysis of glucose utilization in detection of myocardial viability by PET.

Knuuti MJ, Nuutila P, Ruotsalainen U, Teräs M, Saraste M, Härkönen R, Ahonen A, Wegelius U, Haapanen A, Bergman J, et al. Knuuti MJ, et al. Among authors: wegelius u. J Nucl Med. 1993 Dec;34(12):2068-75. J Nucl Med. 1993. PMID: 8254389 Free article.

2

Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography.

Knuuti MJ, Nuutila P, Ruotsalainen U, Saraste M, Härkönen R, Ahonen A, Teräs M, Haaparanta M, Wegelius U, Haapanen A, et al. Knuuti MJ, et al. Among authors: wegelius u. J Nucl Med. 1992 Jul;33(7):1255-62. J Nucl Med. 1992. PMID: 1613561 Free article.

3

FDG-PET in early infancy: simplified quantification methods to measure cerebral glucose utilization.

Suhonen-Polvi H, Ruotsalainen U, Kinnala A, Bergman J, Haaparanta M, Teräs M, M akel a P, Solin O, Wegelius U. Suhonen-Polvi H, et al. Among authors: wegelius u. J Nucl Med. 1995 Jul;36(7):1249-54. J Nucl Med. 1995. PMID: 7790951 Free article.

4

Myocardial viability: fluorine-18-deoxyglucose positron emission tomography in prediction of wall motion recovery after revascularization.

Knuuti MJ, Saraste M, Nuutila P, Härkönen R, Wegelius U, Haapanen A, Bergman J, Haaparanta M, Savunen T, Voipio-Pulkki LM. Knuuti MJ, et al. Among authors: wegelius u. Am Heart J. 1994 Apr;127(4 Pt 1):785-96. doi: 10.1016/0002-8703(94)90545-2. Am Heart J. 1994. PMID: 8154416

5

Different alterations in the insulin-stimulated glucose uptake in the athlete's heart and skeletal muscle.

Nuutila P, Knuuti MJ, Heinonen OJ, Ruotsalainen U, Teräs M, Bergman J, Solin O, Yki-Järvinen H, Voipio-Pulkki LM, Wegelius U, et al. Nuutila P, et al. Among authors: wegelius u. J Clin Invest. 1994 May;93(5):2267-74. doi: 10.1172/JCI117226. J Clin Invest. 1994. PMID: 8182160 Free PMC article.

6

Enhancement of myocardial [fluorine-18]fluorodeoxyglucose uptake by a nicotinic acid derivative.

Knuuti MJ, Yki-Järvinen H, Voipio-Pulkki LM, Mäki M, Ruotsalainen U, Härkönen R, Teräs M, Haaparanta M, Bergman J, Hartiala J, Wegelius U, Nuutila P, et al. Knuuti MJ, et al. Among authors: wegelius u. J Nucl Med. 1994 Jun;35(6):989-98. J Nucl Med. 1994. PMID: 8195886 Free article.

7

Repeated fluorodeoxyglucose positron emission tomography of the brain in infants with suspected hypoxic-ischaemic brain injury.

Suhonen-Polvi H, Kero P, Korvenranta H, Ruotsalainen U, Haaparanta M, Bergman J, Simell O, Wegelius U. Suhonen-Polvi H, et al. Among authors: wegelius u. Eur J Nucl Med. 1993 Sep;20(9):759-65. doi: 10.1007/BF00180905. Eur J Nucl Med. 1993. PMID: 8223769

8

Heart and skeletal muscle glucose disposal in type 2 diabetic patients as determined by positron emission tomography.

Voipio-Pulkki LM, Nuutila P, Knuuti MJ, Ruotsalainen U, Haaparanta M, Teräs M, Wegelius U, Koivisto VA. Voipio-Pulkki LM, et al. Among authors: wegelius u. J Nucl Med. 1993 Dec;34(12):2064-7. J Nucl Med. 1993. PMID: 8254388 Free article.

9

Estimated radiation dose to the newborn in FDG-PET studies.

Ruotsalainen U, Suhonen-Polvi H, Eronen E, Kinnala A, Bergman J, Haaparanta M, Teräs M, Solin O, Wegelius U. Ruotsalainen U, et al. Among authors: wegelius u. J Nucl Med. 1996 Feb;37(2):387-93. J Nucl Med. 1996. PMID: 8667081 Free article.

10

Transport of carbon-11-methionine is enhanced by insulin.

Leskinen S, Pulkki K, Knuuti J, Kirvelä O, Lehikoinen P, Någren K, Ruotsalainen U, Teräs M, Wegelius U, Salminen E. Leskinen S, et al. Among authors: wegelius u. J Nucl Med. 1997 Dec;38(12):1967-70. J Nucl Med. 1997. PMID: 9430478 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters